Est-ce que la décision médicale partagée peut aider à résoudre la difficile équation du choix de la meilleure prise en charge des cancers du bas rectum ?
-
Published:2023-07
Issue:
Volume:
Page:
-
ISSN:1878-786X
-
Container-title:Journal de Chirurgie Viscérale
-
language:fr
-
Short-container-title:Journal de Chirurgie Viscérale
Author:
Brouquet Antoine,
Denost QuentinORCID
Reference7 articles.
1. Recurrence and survival after total mesorectal excision for rectal cancer;Heald;Lancet,1986
2. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer;Kapiteijn;N Engl J Med,2001
3. Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial;Conroy;Lancet Oncol,2021
4. Sphincter-saving surgery after neoadjuvant therapy for ultra-low rectal cancer where abdominoperineal resection was indicated: 10-year results of the GRECCAR 1 trial;Rouanet;Br J Surg,2021
5. Organ preservation for rectal cancer (GRECCAR 2): a prospective, randomised, open-label, multicentre, phase 3 trial;Rullier;Lancet,2017